Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 09, 2004 02:08 ET | Source: Crucell N.V.

Crucell N.V.: Wyeth Selects Novel Drug Targets in Osteoporosis Collaboration With Galapagos

LEIDEN, The Netherlands and MECHELEN, Belgium, Nov. 9, 2004 (PRIMEZONE) -- Galapagos Genomics announced today that it has reached a research milestone in its osteoporosis discovery program with Wyeth...
October 05, 2004 02:08 ET | Source: Crucell N.V.

Galapagos appoints Raj Parekh as Chairman and Wilson Totten to Board of Directors

MECHELEN, Belgium and LEIDEN, The Netherlands, Oct. 5, 2004 (PRIMEZONE) -- Galapagos Genomics NV announced that it has appointed Raj Parekh, Ph.D. as Chairman and Wilson Totten, M.D. to the company's...
September 22, 2004 08:07 ET | Source: Galapagos Genomics

Galapagos announces the separation of its drug discovery and target discovery service -- forms Galadeno(TM) as an independent business unit

MECHELEN, Belgium, Sept. 22, 2004 (PRIMEZONE) -- Galapagos Genomics NV, Europe's leading target discovery company, announced today that it has created a new business unit for its viral based...
June 07, 2004 02:07 ET | Source: Galapagos Genomics

Galapagos Reports Success in Identification and Validation of Proprietary Drug Targets and Moves into Drug Discovery

MECHELEN, Belgium, June 7, 2004 (PRIMEZONE) -- Galapagos Genomics NV, Europe's leading target discovery company, announced today that it has identified, validated and filed patent applications on...
February 12, 2004 02:12 ET | Source: Galapagos Genomics

Galapagos Receives Grant for Alzheimer's Disease Research

MECHELEN, Belgium, Feb. 12, 2004 (PRIMEZONE) -- Galapagos Genomics, the Belgian functional genomics company, today announced that it has been awarded by the IWT (The Flemish Institute for the...
December 16, 2003 02:11 ET | Source: Galapagos Genomics

Bayer Healthcare and Galapagos in Target Discovery Collaboration

MECHELEN, Belgium, Dec. 16, 2003 (PRIMEZONE) -- Galapagos Genomics today announced a target discovery collaboration with Bayer HealthCare AG. Within the partnership, the Companies will collaborate to...
November 13, 2003 02:12 ET | Source: Galapagos Genomics

Wyeth Pharmaceuticals and Galapagos form Discovery Alliance in Osteoporosis

MECHELEN, Belgium, Nov. 13, 2003 (PRIMEZONE) -- Galapagos Genomics today announced that it has entered into a discovery alliance in the field of osteoporosis with Wyeth Pharmaceuticals, the...
November 11, 2003 02:13 ET | Source: Galapagos Genomics

Boehringer Ingelheim and Galapagos Genomics team up in antiviral discovery research program

MECHELEN, Belgium, Nov. 11, 2003 (PRIMEZONE) -- Boehringer Ingelheim and Galapagos Genomics have entered into a collaboration in the field of antiviral discovery research. Under the terms of this...
October 16, 2003 09:22 ET | Source: Galapagos Genomics

Galapagos reports adenoviral siRNA based results

MECHELEN, Belgium, Oct. 16, 2003 (PRIMEZONE) -- Galapagos Genomics today announced that it has published its adenoviral siRNA based gene silencing technology in the scientific journal Genome Research...
June 11, 2003 07:36 ET | Source: Galapagos Genomics

Galapagos Genomics and Procter & Gamble Collaborate in Osteoporosis

MECHELEN, Belgium, June 11, 2003 (PRIMEZONE) -- Galapagos Genomics, a privately held functional genomics company, today announced that it has entered into collaboration with Procter & Gamble...